New Delhi/Hyderabad: Asia’s largest life-sciences and healthcare forum BioAsia, in its 18th edition, has announced a robust line-up of speakers for the event. The list features eminent personalities from business, technology, life sciences, and prominent policymakers. This year’s forum will delve into COVID-19 and beyond, covering the topics of relevance in Global Health, Pharma, and MedTech.
The 2021 edition will discuss the challenges created by Covid-19 and learning opportunities for the future with the over-arching theme, ‘Move the Needle.’ The event will be held on the 22nd and 23rd February 2021. The two-day event will witness several panels focusing on the pandemic and its impact across the globe.
The conference will also discuss India’s role and potential in immunizing the world. A fireside chat titled “Charcha2021 – Healthcare to Hit Refresh” between Mr. KT Rama Rao, and Mr. Satya Nadella, CEO, Microsoft, will be the highlight this year. The discussion will be centered around the opportunities created by the intersection of technology and healthcare/life sciences, digital transformation, role of start-ups, among others.
Detailed speaker list:
-
Dr. Peter Marks, Marks, Director, Center for Biologics Evaluation and Research (CBER), FDA; will deliver the keynote on Day 1.
-
Dr. Sangita Reddy, Joint MD, Apollo Hospitals, and Ms. Debjani Ghosh, President, NASSCOM, Mr. Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare Limited and Ms. Carmen (C.F.M.) van Vilsteren, Chair Top Sector Life Sciences & Health, Health Holland will participate in a panel discussion on “Virtually connected Healthcare”. The panel will focus on increasing virtulization of patient journey due to Covid-19.
-
The conference will also host an in-depth session on “Immunizing the World”. The session will delve into India’s current role and potential to become a global innovative vaccine provider. The session will feature the following speakers:
-
Dr. Soumya Swaminathan, Deputy Director-General of Programmes (DDP), World Health Organization;
-
Dr. Balram Bhargava, Secretary, Government of India, Department of Health Research, Ministry of Health & Family Welfare & Director-General, Indian Council of Medical Research;
-
Dr. Robin Nandy, Principal Advisor & Chief of Immunizations, UNICEF
-
Dr. Jerome H. Kim, Director General, International Vaccine Institute (IVI), South Korea
-
Dr. Krishna Ella, CMD, Bharat Biotech International Ltd
-
Ms. Mahima Datla, Managing Director, Biological E
-
Dr. Trevor Mundel, President (Global Health), Bill and Melinda Gates Foundation, will deliver a special address on the learnings from the pandemic. The following speakers will further elaborate on the topic in a panel discussion-
-
Dr. VK Paul, Member (Health), Niti Aayog, Government of India
-
Dr. Renu Swarup, Secretary to Government of India, Department of Biotechnology
-
Dr. Peter Piot, Director, London School of Hygiene and Tropical Medicine
-
Dr. Richard Hatchett, Chief Executive Officer, Coalition for Epidemic Preparedness Innovations (CEPI)
-
Dr. Naresh Trehan, Chairman and Managing Director, Medanta Hospital
-
-
Day 2 sessions will focus on sector specific sessions for Pharma and Medical Devices. Further, there is also a spotlight session centered around start-ups – “Creating Unicorns” by Mr. George Bickerstaff, Co-founder and Managing Director, M.M. Dillon & Co., Former CFO, Novartis and Dr. Jo Bury, CEO of VIB (Flemish Institute of Biotechnology).
-
The session on Medical Technologies – The next big opportunity for India aims at deliberating the strategy required to accelerate the the journey of India from primary importers to large scale exporters. Following sector leaders will be joining for the session:
-
Ms. S. Aparna, Secretary, Dept. of Pharmaceuticals, Government of India
-
Mr. Madan R Krishnan, VP-MD India Subcontinent (South Asia), Medtronic
-
Mr. Bhargav Kotadia, Managing Director, SMT
-
Mr. Shravan Subramanyam, President, GE, India & South Asia
-
Mr. Suresh Vazirani, Chairman and Managing Director, Transasia Bio-Medicals Ltd.
-
Mr. Jayesh Ranjan IAS, Principal Secretary, Industries & Commerce Dept., Government of Telangana
-
Mr. Rajiv Nath, Jt. Managing Director, Hindustan Syringes & Medical Devices Ltd & Forum Coordinator, AiMeD
-
A session on “Reimagining R&D post COVID – Collaboration, Data and Repurposing” which will witness the participation of Global R&D leaders such as
-
Mr. Andy Plump, President R&D, Takeda
-
Mr. Lutz Hegemann, Group Head of Corporate Affairs and Global Health, Novartis
CEO conclave has been one of the highlight events of BioAsia over the years and this year’s edition too will have a line-up of influential leaders of the sector deliberating on How India could transition from ‘Pharmacy of the World’ to ‘Global Life Sciences innovation hub’ with the topic of “Pursuit for Innovation”and consolidate its position further globally as the life sciences capital of the world. The panelists include:
-
-
Mr. KT Rama Rao, Minister for Industries & Commerce, Government of Telangana
-
Mr. Amitabh Kant, Chief Executive Officer, NITI Aayog, Government of India
-
Mr. Satish Reddy, Chairman, Dr. Reddy’s Laboratories Ltd.
-
Mr. Nilesh Gupta, Managing Director, Lupin Ltd.
-
Ms. Kiran Majumdar Shaw, CMD, Biocon Ltd.
-
Mr. Sriram Shrinivasan, India Life Sciences Leader, EY
-
